Shares of Universal (NYSE:UVV) are trading at $47.75, down 6.08% in the current session and off 3.51% over the past week. The slide follows a badly missed fiscal Q1 earnings report and pushes the leaf-tobacco merchant below its 52-week low of $47.66, breaking a support level that had held for months.
Earnings Miss Sparks a Fresh Leg Lower
Universal reported first-quarter fiscal 2027 results after the close on August 5, 2026, and the numbers were ugly. Adjusted EPS came in at -$0.20, missing the $0.25 consensus. Revenue of $523.78 million came in short of the $587.00 million estimate, a decline of 11.79% year over year.
The damage was concentrated in the core Tobacco Operations segment, where revenue fell 13% year over year to $437.13 million and operating income collapsed 90% to $3.47 million. Tobacco volumes were down 9% and prices down 6%, reflecting oversupply in flue-cured and burley markets. The Ingredients segment fared no better, with revenue of $86.65 million and a segment operating loss driven by weak CPG demand and elevated fixed costs at the expanded Lancaster facility.
Gross margin compressed 330 basis points to 15.9%, and operating income fell 93.23% to $2.30 million. CEO Preston Wigner acknowledged the environment, saying “Purchasing activity was slower as we and our customers evaluated green tobacco price trends amid oversupply conditions in flue-cured and burley markets.” This is the fourth consecutive quarterly disappointment, following a -142.59% EPS miss in Q4 FY26 that included a $41.06 million goodwill impairment.
The Drop Is a Universal-Specific Story
Peer action confirms this is a Universal-specific problem. The table below shows today’s move alongside the past week for the group.
| Ticker | Company | Today | Past Week | Market Cap / Yield |
|---|---|---|---|---|
| UVV | Universal | -6.08% | -3.51% | $1.27B / 6.43% |
| MO | Altria | -1.75% | +0.03% | $114B / 6.26% |
| PM | Philip Morris | -0.69% | -0.66% | $295B / 3.13% |
| TPB | Turning Point Brands | +2.74% | +16.42% | $1.68B / 0.36% |
Altria and Philip Morris are trading only modestly lower, and both reported clean beats in their most recent quarters, with Philip Morris raising its FY26 EPS guide to $8.26 to $8.41 on IQOS and ZYN strength. Turning Point Brands is the outlier in the other direction, up 16.42% on the week after its Q2 2026 earnings report on August 4 showed Modern Oral pouch revenue up 149%. The S&P 500 rose 3.51% over the same week, underscoring that UVV’s slide is a single-name story tied to leaf-tobacco oversupply and Universal’s ingredients drag.
What to Watch Next
The bull case still rests on the dividend and shipment timing. Universal declared its next $0.83 quarterly payout with a November 2, 2026 payment date, extending the streak to 56 consecutive years and pushing the yield to 6.43%. Management expects tobacco shipments to weight to the second half of FY27.
Contact [email protected] for any questions or corrections.